Palomino Laboratories Inc.
PALX
$15.32
-$0.08-0.52%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.51% | 8.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.79% | 67.47% | |||
| Operating Income | -9.79% | -67.47% | |||
| Income Before Tax | -9.78% | -67.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.78% | -67.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.78% | -67.44% | |||
| EBIT | -9.79% | -67.47% | |||
| EBITDA | -9.03% | -- | |||
| EPS Basic | 6.85% | -68.84% | |||
| Normalized Basic EPS | 6.90% | -68.67% | |||
| EPS Diluted | 6.85% | -68.84% | |||
| Normalized Diluted EPS | 6.90% | -68.67% | |||
| Average Basic Shares Outstanding | 17.86% | -0.67% | |||
| Average Diluted Shares Outstanding | 17.86% | -0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||